Zynex moves COO Anna Lucsok to Chief Commercial Officer

Zynex, Inc. reported a leadership role change for one of its senior executives.

Rhea-AI Filing Summary

Zynex, Inc. reported a leadership role change for one of its senior executives. Effective September 16, 2025, Anna Lucsok transitioned from serving as Chief Operating Officer to serving as the company’s Chief Commercial Officer. She will continue as an executive officer, meaning she remains part of the top management team. As part of this change, her prior responsibilities for overseeing manufacturing, information technology, and regulatory matters were re-allocated within the company to other areas or leaders. The filing does not describe changes to compensation or other terms, focusing instead on clarifying her new commercial-focused role.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive change did Zynex (ZYXI) disclose in this 8-K?

Zynex disclosed that, effective September 16, 2025, Anna Lucsok transitioned from the role of Chief Operating Officer to Chief Commercial Officer while remaining an executive officer of the company.

Does Anna Lucsok remain an executive officer of Zynex (ZYXI)?

Yes. The filing states that following her title change to Chief Commercial Officer, Ms. Lucsok will continue to serve as an executive officer of Zynex.

What responsibilities changed for Anna Lucsok at Zynex (ZYXI)?

With her move to Chief Commercial Officer, Ms. Lucsok’s responsibility for overseeing manufacturing, information technology and regulatory matters was re-allocated within the company.

When did the leadership change for Anna Lucsok at Zynex take effect?

The transition from Chief Operating Officer to Chief Commercial Officer for Anna Lucsok became effective on September 16, 2025, which is the event date described in the report.

Who signed the Zynex (ZYXI) 8-K reporting this officer transition?

The report was signed on behalf of Zynex, Inc. by Steven Dyson, who is identified in the document as the company’s Chief Executive Officer.

Does this Zynex (ZYXI) filing mention changes to compensation for Anna Lucsok?

The content provided focuses on Ms. Lucsok’s title and responsibility change and does not describe any compensation-related changes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/22/2025 - 05:00 PM EDT Learn about SEC filing dates

0000846475false00008464752025-09-162025-09-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

​

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): September 16, 2025

​

​

Zynex, Inc.

(Exact Name of Registrant as Specified in its Charter)

​

​

Nevada	001-38804	90-0275169
(State or other jurisdiction of incorporation)	Commission File Number	(I.R.S. Employer Identification number)

​

​

9655 Maroon Circle, Englewood, CO 80112

(Address of principal executive offices) (Zip Code)

​

Registrant’s telephone number, including area code: (800) 495-6670

​

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

d
☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Title of each class	Ticker symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	ZYXI	The Nasdaq Stock Market LLC

​

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

​

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

​

On September 16, 2025, Anna Lucsok transitioned from serving as the Chief Operating Officer of Zynex. Inc. (the “Company”) to serving as the Company’s Chief Commercial Officer.  In connection with her title change, Ms. Lucsok will continue to serve as an executive officer of the Company, but her responsibility for overseeing manufacturing, information technology and regulatory matters was re-allocated within the Company.

​

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​	​	​
​	ZYNEX, INC.
​	​	​
Dated: September 22, 2025	By:	/s/ Steven Dyson
​	Name:	Steven Dyson
​	Title:	Chief Executive Officer

​

​

​